Macrocure logo
Macrocure to Host and Webcast Analyst & Investor Day on February 12, 2015
January 09, 2015 08:00 ET | Macrocure
Company to Provide Comprehensive Review of Mechanism of Action Study Results and Patient Case Studies Five Physicians to Present and Host Question and Answer Session PETACH TIKVA, Israel, Jan....
Macrocure logo
Macrocure Ltd. Featured in Five News Outlets
December 15, 2014 08:00 ET | Macrocure
PETACH TIKVA, Israel, Dec. 15, 2014 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
Macrocure logo
Macrocure Announces Completion of Mechanism of Action Study
December 11, 2014 07:00 ET | Macrocure
PETACH TIKVA, Israel, Dec. 11, 2014 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic...
Macrocure logo
Macrocure Ltd. to Present at Upcoming Oppenheimer Healthcare Conference
December 01, 2014 08:00 ET | Macrocure
PETACH TIKVA, Israel, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
Macrocure logo
Macrocure Announces Special General Meeting of Shareholders for Approval of Compensation Policy
November 25, 2014 08:00 ET | Macrocure
PETACH TIKVA, Israel, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic...
Macrocure logo
Macrocure Ltd. Announces Third Quarter 2014 Financial Results
November 03, 2014 16:05 ET | Macrocure
Completed patient enrollment in Pivotal, Phase III Diabetic Foot Ulcer clinical trial Pivotal, Phase III Venous Leg Ulcerclinical trial is showing strong recruitment rates PETACH TIKVA, Israel,...
Macrocure logo
Macrocure Ltd Announces Third Quarter 2014 Financial Results Date and Conference Call
October 21, 2014 08:00 ET | Macrocure
PETACH TIKVA, Israel, Oct. 21, 2014 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
Macrocure logo
Macrocure Ltd. to Present at Upcoming Nomura, Credit Suisse and Jefferies Health Care Conferences in November
October 16, 2014 08:00 ET | Macrocure
PETACH TIKVA, Israel, Oct. 16, 2014 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...
Macrocure logo
Macrocure Nominates Katherine Wolf and Yuval Yanai for Election to Board of Directors and Announces Special General Meeting of Shareholders
October 01, 2014 10:15 ET | Macrocure
PETACH TIKVA, Israel, Oct. 1, 2014 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic...
Macrocure logo
Macrocure Ltd. Completes Enrollment in Pivotal Phase III Clinical Trial of CureXcell in Diabetic Foot Ulcers
September 02, 2014 11:25 ET | Macrocure
PETACH TIKVA, Israel, Sept. 2, 2014 (GLOBE NEWSWIRE) -- Macrocure Ltd. (Nasdaq:MCUR), a clinical-stage biotechnology company focused on developing a novel therapeutic platform to address chronic and...